Evidence map›Paper›PMID 39057401›Full record

ArticleMarine drugs2024

Tunicamycins from Marine-Derived

Jayho Lee, Ji-Yeon Hwang, Daehyun Oh, Dong-Chan Oh, Hyeung-Geun Park, Jongheon Shin, Ki-Bong Oh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Marine natural products.Natural product reports · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jayho LeeDepartment of Agricultural Biotechnology, College of Agriculture and Life Sciences and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Ji-Yeon HwangNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Daehyun OhResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Dong-Chan OhNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0001-6405-5535
Hyeung-Geun ParkResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Jongheon ShinNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0002-7536-8462
Ki-Bong OhDepartment of Agricultural Biotechnology, College of Agriculture and Life Sciences and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.

Funding

Basic Science Research Program through the National Research Foundation of Korea 2021R1F1A1048154
6 · The paper itself

Abstract

Four tunicamycin class compounds, tunicamycin VII (

Indexed as

Anti-Bacterial AgentsBacterial ProteinsMicrobial Sensitivity TestsStaphylococcus aureusStreptomycesTunicamycinAquatic OrganismsTransferasesTransferases (Other Substituted Phosphate Groups)Anti-Bacterial AgentsBacterial ProteinsmraY protein, BacteriaTransferasesTransferases (Other Substituted Phosphate Groups)Tunicamycinantibacterial activityMurNAc-pentapeptide translocaseStaphylococcus aureusStreptomyces bacillaristunicamycins

Identifiers

PMID39057401
PMCPMC11277991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.